Manorama Industries Limited

Manorama Industries Limited

MANORAMA.BO
Manorama Industries LimitedIN flagBombay Stock Exchange
1,576.35
INR
+10.90
- -
93.94BMarket Cap
Manorama Industries Limited
MANORAMA.BO
(Bombay Stock Exchange)

Recent

price

1,576.35

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
18.63
22.96
23.49
26.01
39.4
21.59
33.17
35.78
47.76
58.43
76.47
129.33
- -
155.5
Revenue per Share
0.16
0.17
0.19
0.25
1.79
4.05
4.19
2.62
4.15
5
6.73
18.42
- -
24.02
Basic EPS, GAAP
0.03
1.87
0.24
1.92
-2.49
-7.49
-16.32
5.22
-16
1.34
-32.31
-14.89
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.4
0.4
- -
- -
Dividend per Share
1.19
1.36
1.62
1.87
4.37
9.98
13.13
15.76
19.38
23.91
30.24
48.24
- -
- -
Book Value per Share
1.55
1.73
2.34
2.58
4.37
22.09
23.38
26.01
46.13
49.93
56.43
76.74
- -
- -
Tangible Book Value per Share
56
56
56
56
56
47
56
56
58
60
60
60
- -
60
Basic Weighted Avg Shares
1,037
1,278
1,307
1,447
2,192
1,015
1,845
1,991
2,778
3,482
4,558
7,708
13,667
9,270
Sales/Revenue/Turnover
3.05
1
2.24
1.18
7.34
27.75
19.61
13.41
11.21
13.09
13.15
21.31
23.83
22.72
Operating Margin (%)
6
7
9
8
7
8
77
80
79
109
136
221
257
237
Depreciation Expense
9
9
11
14
99
191
233
146
241
298
401
1,098
2,149
1,432
Net Income, GAAP
27.58
34.62
35.23
32.83
37.63
28.24
27.9
34.79
27.96
30.85
24.57
24.84
27.92
25.94
Effective Tax Rate (%)
0.86
0.74
0.83
0.95
4.53
18.77
12.65
7.33
8.69
8.55
8.8
14.24
15.73
15.45
Profit Margin (%)
63
70
100
114
201
689
608
887
1,849
1,743
2,131
3,166
4,504
- -
Working Capital
2
3
1
- -
1
5
5
151
298
240
507
440
337
- -
LT Debt
86
96
130
144
243
1,039
1,301
1,447
2,683
2,983
3,370
4,597
6,722
- -
Total Equity
- -
4.94
12.01
7.08
35.38
23.7
13.41
6.98
7.27
8
8.28
15.13
23.65
- -
Return on Invested Capital (%)
- -
15.34
14.56
14.96
41.41
38.92
22.5
11.3
14.03
14.86
13.9
21.48
42.59
95.95
Return on Capital (%)
- -
13.29
13.04
14.14
57.21
53.5
38.88
18.14
24.1
23.34
24.86
46.95
143.56
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
4,383
- -
LT Borrowings
- -
429
- -
LT Finance Leases
- -
11
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
60
- -
Market Capitalization
63,962
63,324
87,164

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
7,902
- -
Cash, Cash Equivalents & STI
- -
979
- -
Accounts Receivable, Net
- -
1,017
- -
Inventories
- -
5,505
- -
Total Current Liabilities
- -
4,736
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
4,383
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
63.59%
38.43%
46.21%
Free Cash Flow
-275.43%
-683.74%
-320.44%
Net Income, GAAP
111.92%
78.62%
95.78%
Sales/Revenue/Turnover
34.03%
48.44%
77.3%
Total Cash Common Dividend
- -
- -
50.03%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,116
1,177
985
1,280
4,558
2025
1,334
1,954
2,092
2,328
7,708
2026
2,896
3,625
3,913
- -
13,667

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.94
1.44
1.25
- -
6.73
2025
2.27
4.32
5.11
6.72
18.42
2026
7.87
12.1
7.12
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.4
2025
- -
- -
- -
- -
0.4
2026
- -
- -
- -
- -
- -
Business
Manorama Industries Limited (MANORAMA.BO) manufactures and sells specialty fats and butters derived from tree-borne oils for the confectionery, chocolate, bakery, cosmetics, and pharmaceutical industries. The company offers products such as shea butter, mango butter, sal butter, cocoa butter equivalents, milk fats, and fractionated fats, marketed under brands including Marinol, Manopro, and Salpro; it also provides contract manufacturing services and value-added processing of exotic butters. Headquartered in Ahmedabad, India, and founded in 2005, Manorama operates production facilities primarily in India with exports to Europe, North America, Asia, and other regions, targeting food processors, personal care brands, and nutraceutical firms. In recent developments, the company expanded its capacity through a greenfield plant commissioning in 2024 and secured strategic export approvals for key markets; it also announced a funding round via qualified institutional placement in late 2024 to support growth in sustainable sourcing and organic certifications.